Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;12(11):670-80.
doi: 10.1038/nrcardio.2015.108. Epub 2015 Jul 21.

Viral Myocarditis--Diagnosis, Treatment Options, and Current Controversies

Affiliations
Review

Viral Myocarditis--Diagnosis, Treatment Options, and Current Controversies

Ari Pollack et al. Nat Rev Cardiol. .

Abstract

Myocarditis--a frequent cause of dilated cardiomyopathy and sudden cardiac death--typically results from cardiotropic viral infection followed by active inflammatory destruction of the myocardium. Characterization of this disease has been hampered by its heterogeneous clinical presentations and diverse aetiologies. Advances in cardiac MRI and molecular detection of viruses by endomyocardial biopsy have improved our ability to diagnose and understand the pathophysiological mechanisms of this elusive disease. However, therapeutic options are currently limited for both the acute and chronic phases of myocarditis. Several randomized, controlled trials have demonstrated potential benefit with immunosuppressive and immunomodulatory therapies, but further investigations are warranted. In this Review, we explore the pathophysiology, natural history, and modes of diagnosis of myocarditis, as well as evidence-based treatment strategies. As novel imaging techniques and human in vitro models of the disease emerge, the landscape of therapies for myocarditis is poised to improve.

Similar articles

See all similar articles

Cited by 54 articles

See all "Cited by" articles

References

    1. Eur Heart J. 2008 Sep;29(17):2073-82 - PubMed
    1. N Engl J Med. 1995 Aug 3;333(5):269-75 - PubMed
    1. Circulation. 2001 Jul 3;104(1):39-45 - PubMed
    1. Circulation. 2006 Apr 11;113(14):1807-16 - PubMed
    1. JAMA. 2006 Oct 18;296(15):1867-76 - PubMed

Substances

Feedback